CHIARAMONTE, RAFFAELLA
CHIARAMONTE, RAFFAELLA
Dipartimento di Scienze della Salute
A new strategy for selective NOTCH2 targeting in multiple myeloma based on small molecules hampering receptor-ligand interaction
2017 N. Platonova, C. Parravicini, L. Palazzolo, S. Saporiti, M. Colombo, V. Vallelonga, R. Colella, F. Baccianti, A. Neri, I. Eberini, R. Chiaramonte
A new strategy of selective Notch receptor targeting in multiple myeloma based on small molecules
2018 N. Platonova, C. Parravicini, L. Palazzolo, S. Saporiti, M. Colombo, V. Vallelonga, D. Giannandrea, A. Neri, I. Eberini, R. Chiaramonte
A new therapeutic strategy in multiple myeloma based on small molecules directed to notch pathway
2018 N. Platonova, C. Parravicini, L. Palazzolo, S. Saporiti, M. Colombo, V. Vallelonga, D. Giannandrea, D. Giana, A. Neri, I. Eberini, R. Chiaramonte
A novel Notch-targeted therapeutic approach in multiple myeloma based on small molecules disrupting Notch-Jagged interaction
2015 N. Platonova, A. Paoli, I. Eberini, C. Sensi, C. Parravicini, M. Colombo, A. Neri, R. Chiaramonte
A novel therapeutic approach targeted notch in multiple myeloma based on small molecules uncoupling receptor-ligand interaction
2016 N. Platonova, I. Eberini, C. Sensi, C. Parravicini, A.S.F. De Paoli, M. Colombo, S. Garavelli, M. Palano, A. Neri, R. Chiaramonte
A wide role for NOTCH1 signaling in acute leukemia
2005 R. Chiaramonte, A. Basile, E. Tassi, E. Calzavara, V. Cecchinato, V. Rossi, A. Biondi, P. Comi
ADAR1-dependent RNA editing is a mechanism of therapeutic resistance in human plasma cell malignancies
2016 E. Lazzari, L. Crews, C. Wu, H. Leu, S. Ali, R. Chiaramonte, M. Minden, C. Costello, C.H.M. Jamieson
AKT positively regulates Notch pathway in T-cell acute lymphoblastic leukemia
2010 N. Platonova, L. Mirandola, S. Carluccio, M. Colombo, R. Chiaramonte, P. Comi
AKT promotes the oncogenic Notch signaling in T-cell acute lymphoblastic leukemia
2014 N. Platonova, L. Mirandola, E. Vigolo, G. Cermisoni, D. De Simone, S. Garavelli, E. Lazzari, M. Colombo, A. Neri, R. Chiaramonte
AKT regulation of oncogenic Notch pathway in T-cell acute lymphoblastic leukemia
2015 N. Platonova, E. Vigolo, G. Cermisoni, D. De Simone, M. Colombo, S. Garavelli, E. Lazzari, S. Galletti, A. Paoli, A. Neri, R. Chiaramonte
Allele frequency of two intragenic microsatellite loci of SEL1L gene in Northern Italy population
2002 R. Chiaramonte, M. Sabbadini, P. Comi, G. V. Sherbet
Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma
2017 E. Lazzari, P. Mondala, N. Santos, A. Miller, G. Pineda, Q. Jiang, H. Leu, S. Ali, A. Ganesan, C. Wu, C. Costello, M. Minden, R. Chiaramonte, A. Stewart, L. Crews, C. Jamieson
Anti-Notch treatment prevents Multiple myeloma cell localization to the bone marrow via chemokine system CXCR4/SDF-1
2012 L. Mirandola, M. Colombo, L. Apicella, G. Berta, N. Platonova, M. Chiriva Internati, R. Chiaramonte
Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1
2013 L. Mirandola, L. Apicella, M. Colombo, Y. Yuefei, D.G. Berta, N. Platonova, E. Lazzari, M. Lancellotti, G. Bulfamante, E. Cobos, M. Chiriva Internati, R. Chiaramonte
Bone marrow-mediated drug resistance is promoted by Jagged-induced notch pathway in multiple myeloma
2015 S. Garavelli, E. Lazzari, M. Colombo, A. Paoli, N. Platonova, S. Galletti, K. Todoerti, A. Neri, R. Chiaramonte
Bone marrow-mediated drug resistance is promoted by Jagged-induced Notch signaling in multiple myeloma
2014 S. Garavelli, E. Lazzari, M. Colombo, S. Ravaioli, N. Platonova, M. Lancellotti, L. Apicella, L. Mirandola, S. Galletti, K. Todoerti, A. Neri, R. Chiaramonte
Burkitt lymphoma translocation turns Notch over to the dark side
2009 L. Mirandola, A. Basile, P. Comi, R. Chiaramonte
Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu
2018 M. Colombo, L. Mirandola, M. Chiriva-Internati, A. Basile, M. Locati, E. Lesma, R. Chiaramonte, N. Platonova
Cancer testes antigens in breast cancer : biological role, regulation and therapeutic applicability
2012 A. Pandey, A. Kurup, A. Shrivastava, S. Radhi, D.D. Nguyen, C. Arentz, N. D'Chuna, F. Hardwick, M.J. D'Souza, M. Jenkins, F. Grizzi, W.M. Kast, E. Cobos, R. Rahman, M. Chiriva Internati, R. Chiaramonte, N. Platonova
Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapy
2017 L. Mirandola, J.A. Figueroa, R. Chiaramonte, M. Colombo, E. Pedretti, N. Daver, P. Ruvolo, S. Post, C. Chapman, F. Grizzi, F. Patrinicola, W. Martin Kast, M.J. Cannon, D.D. Nguyen, R. Layeequr Rahman, R.S. Bresalier, M. Chiriva Internati